Published in Front Physiol on December 22, 2014
Aberrant Glycosylation in the Left Ventricle and Plasma of Rats with Cardiac Hypertrophy and Heart Failure. PLoS One (2016) 0.75
Triptolide Upregulates Myocardial Forkhead Helix Transcription Factor p3 Expression and Attenuates Cardiac Hypertrophy. Front Pharmacol (2016) 0.75
Editorial: Cardiac electronic remodeling and susceptibility to arrhythmias: an introduction and brief historical overview. Front Physiol (2015) 0.75
Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application. Int J Mol Sci (2017) 0.75
Remodeling of Repolarization and Arrhythmia Susceptibility in a Myosin Binding Protein C Knockout Mouse Model. Am J Physiol Heart Circ Physiol (2017) 0.75
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell (1998) 13.56
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
Hypertrophic cardiomyopathy: a systematic review. JAMA (2002) 9.15
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation (1996) 9.00
Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation (2002) 8.49
Tissue- and site-specific DNA recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 6.94
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation (2010) 6.71
Ligand-activated site-specific recombination in mice. Proc Natl Acad Sci U S A (1996) 6.48
Basic mechanisms of cardiac impulse propagation and associated arrhythmias. Physiol Rev (2004) 5.79
The action of ions upon the frog's heart. J Physiol (1921) 5.54
Cardiac malformation in neonatal mice lacking connexin43. Science (1995) 5.51
Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med (1988) 5.22
Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet (2000) 4.54
Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA (2006) 4.51
Molecular mechanisms of myocardial remodeling. Physiol Rev (1999) 4.27
Characterization of conduction in the ventricles of normal and heterozygous Cx43 knockout mice using optical mapping. J Cardiovasc Electrophysiol (1999) 4.08
Specific permeability and selective formation of gap junction channels in connexin-transfected HeLa cells. J Cell Biol (1995) 4.08
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1. Cardiovasc Res (2005) 3.99
Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res (2004) 3.93
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a. Proc Natl Acad Sci U S A (2002) 3.59
Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease). Heart Rhythm (2004) 3.54
Spatial distribution of fibrosis governs fibrillation wave dynamics in the posterior left atrium during heart failure. Circ Res (2007) 3.51
Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation (2006) 3.44
Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet (2000) 3.39
Ca2+/calmodulin-dependent protein kinase II regulates cardiac Na+ channels. J Clin Invest (2006) 3.33
Disturbed connexin43 gap junction distribution correlates with the location of reentrant circuits in the epicardial border zone of healing canine infarcts that cause ventricular tachycardia. Circulation (1997) 3.33
Slow conduction in the infarcted human heart. 'Zigzag' course of activation. Circulation (1993) 3.13
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2002) 2.95
Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res (1996) 2.91
Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation. Circulation (1988) 2.86
Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene. Am J Hum Genet (2008) 2.84
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation (2006) 2.81
Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy. Circulation (2012) 2.78
Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res (2002) 2.59
Dephosphorylation and intracellular redistribution of ventricular connexin43 during electrical uncoupling induced by ischemia. Circ Res (2000) 2.57
Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes. Circ Res (2009) 2.48
Epidermolytic palmoplantar keratoderma with woolly hair and dilated cardiomyopathy. J Am Acad Dermatol (1998) 2.29
Targeted mutation of plakoglobin in mice reveals essential functions of desmosomes in the embryonic heart. J Cell Biol (1996) 2.27
Arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2. Am J Hum Genet (2006) 2.26
Electrical propagation in synthetic ventricular myocyte strands from germline connexin43 knockout mice. Circ Res (2004) 2.25
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol (2012) 2.25
SAP97 and dystrophin macromolecular complexes determine two pools of cardiac sodium channels Nav1.5 in cardiomyocytes. Circ Res (2010) 2.24
Slow conduction and enhanced anisotropy increase the propensity for ventricular tachyarrhythmias in adult mice with induced deletion of connexin43. Circulation (2004) 2.23
Reduced heterogeneous expression of Cx43 results in decreased Nav1.5 expression and reduced sodium current that accounts for arrhythmia vulnerability in conditional Cx43 knockout mice. Heart Rhythm (2011) 2.21
Mechanisms underlying conduction slowing and arrhythmogenesis in nonischemic dilated cardiomyopathy. Circ Res (2004) 2.19
The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol (2010) 2.18
High resolution optical mapping reveals conduction slowing in connexin43 deficient mice. Cardiovasc Res (2001) 2.16
Altered connexin expression in human congestive heart failure. J Mol Cell Cardiol (2001) 2.15
Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens (1995) 2.15
Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol (1994) 2.12
Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation (2001) 2.11
Heterogeneous gap junction remodeling in reentrant circuits in the epicardial border zone of the healing canine infarct. Cardiovasc Res (2006) 2.08
Reduced content of connexin43 gap junctions in ventricular myocardium from hypertrophied and ischemic human hearts. Circulation (1993) 2.05
Sudden cardiac death. Structure, function, and time-dependence of risk. Circulation (1992) 2.04
Interactions between ankyrin-G, Plakophilin-2, and Connexin43 at the cardiac intercalated disc. Circ Res (2011) 1.95
Dynamic changes in conduction velocity and gap junction properties during development of pacing-induced heart failure. Am J Physiol Heart Circ Physiol (2007) 1.94
Altered patterns of gap junction distribution in ischemic heart disease. An immunohistochemical study of human myocardium using laser scanning confocal microscopy. Am J Pathol (1991) 1.93
Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation. J Cell Biol (2004) 1.92
A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2007) 1.91
Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy. Heart Rhythm (2012) 1.91
Diagnosis and classification of myocarditis by endomyocardial biopsy. N Engl J Med (1983) 1.90
Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks. Heart Rhythm (2010) 1.85
Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol (1996) 1.83
Slow ventricular conduction in mice heterozygous for a connexin43 null mutation. J Clin Invest (1997) 1.83
Structural and molecular pathology of the heart in Carvajal syndrome. Cardiovasc Pathol (2004) 1.82
Heterogeneous loss of connexin43 protein in nonischemic dilated cardiomyopathy with ventricular tachycardia. J Cardiovasc Electrophysiol (2002) 1.82
Losing heart: the role of apoptosis in heart disease--a novel therapeutic target? FASEB J (2002) 1.81
Transmural heterogeneity and remodeling of ventricular excitation-contraction coupling in human heart failure. Circulation (2011) 1.80
Gap junctions in cardiovascular disease. Circ Res (2000) 1.77
Arrhythmogenic right ventricular cardiomyopathy: diagnosis, prognosis, and treatment. Heart (2000) 1.77
Overlap syndrome of cardiac sodium channel disease in mice carrying the equivalent mutation of human SCN5A-1795insD. Circulation (2006) 1.76
Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging. Circulation (2005) 1.74
Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. Circ Res (2000) 1.74
Up-regulation of connexin45 in heart failure. J Cardiovasc Electrophysiol (2003) 1.73
Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J (1986) 1.73
Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol (1999) 1.71
Reactive oxygen species-activated Ca/calmodulin kinase IIδ is required for late I(Na) augmentation leading to cellular Na and Ca overload. Circ Res (2011) 1.69
Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis. Circulation (2005) 1.69
Alterations of sodium channel kinetics and gene expression in the postinfarction remodeled myocardium. J Cardiovasc Electrophysiol (2001) 1.68
Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy. Am J Hum Genet (2006) 1.68
Myofibroblasts in diseased hearts: new players in cardiac arrhythmias? Heart Rhythm (2009) 1.66
Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci (1999) 1.65
Hypertrophy causes delayed conduction in human and guinea pig myocardium: accentuation during ischaemic perfusion. Cardiovasc Res (1994) 1.63
Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. Cardiovasc Pathol (2004) 1.62
Gap junction remodeling and altered connexin43 expression in the failing human heart. Mol Cell Biochem (2003) 1.61
Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation (2013) 1.61
Aging and Cardiac Fibrosis. Aging Dis (2011) 1.58
Cardiac cell-cell junctions in health and disease: Electrical versus mechanical coupling. J Mol Cell Cardiol (2009) 1.58
Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res (1989) 1.57
Mechanisms of unpinning and termination of ventricular tachycardia. Am J Physiol Heart Circ Physiol (2006) 1.55
In silico cardiac risk assessment in patients with long QT syndrome: type 1: clinical predictability of cardiac models. J Am Coll Cardiol (2012) 1.53
Disparate effects of deficient expression of connexin43 on atrial and ventricular conduction: evidence for chamber-specific molecular determinants of conduction. Circulation (1998) 1.51
Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail (2012) 1.51
Connexin 43 expression and distribution in compensated and decompensated cardiac hypertrophy in patients with aortic stenosis. Cardiovasc Res (2004) 1.49
Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload. Histochem Cell Biol (2008) 1.45
Electrophysiologic remodeling of the left ventricle in pressure overload-induced right ventricular failure. J Am Coll Cardiol (2012) 1.44
Impulse propagation in synthetic strands of neonatal cardiac myocytes with genetically reduced levels of connexin43. Circ Res (2003) 1.44
Alterations at the intercalated disk associated with the absence of muscle LIM protein. J Cell Biol (2001) 1.43